Put this in your pipe and smoke it: A Kansas lawmaker thinks marijuana should be illegal because he said black people are genetically unable to handle its effects.
State Rep. Steve Alford (R) spoke out on Saturday against legalizing pot using the type of racist “logic” commonly heard when “Reefer Madness” was considered a serious documentary.
“What you really need to do is go back in the ’30s, when they outlawed all types of drugs in Kansas [and] across the United States,” Alford said, according to the Garden City Telegram. “One of the reasons why, I hate to say it, was that the African-Americans, they were basically users and they basically responded the worst off to those drugs just because of their character makeup, their genetics and that.”
You can hear Alford make his anti-cannabis comments in the video below:
The Telegram pointed out that Alford’s comments appeared to be based on the theories of Harry Anslinger, the founding commissioner of what was then called the Federal Bureau of Narcotics, which was behind the Marijuana Tax Act of 1937.
“Reefer makes darkies think they’re as good as white men.”
“There are 100,000 total marijuana smokers in the U.S., and most are Negroes, Hispanics, Filipinos and entertainers. Their Satanic music, jazz and swing result from marijuana use. This marijuana causes white women to seek sexual relations with Negroes, entertainers and any others.”
“Marijuana is an addictive drug which produces in its users insanity, criminality, and death.”
Although Alford, who represents a district in western Kansas, stood by his remarks when questioned after the meeting, he was unable to cite a specific source for his so-called science to the Telegram. However, he admitted he shouldn’t have singled out African-Americans.
“There are certain groups of people, their genetics, the way their makeup is, the chemicals will affect them differently,” Alford insisted. “What I should have said was drugs affect people differently, instead of being more specific.”
On Monday, Alford denied that his remarks were racist to AP: “To me, that’s neutral. Basically, I got called a racist, which I’m really not, and it’s just the way people — the interpretation of people. To me, I’m trying to look at what’s really the best for Kansas.”
Carl Brewer, a Democratic candidate for governor, said Alford’s comments were inappropriate for a politician in 2018.
“It is hard to believe that in 2018, anyone would support the discredited and racist policies of the Jim Crow-era,” Brewer said in a statement to KSN TV. “No matter one’s feelings on medical marijuana and marijuana legalization, we can all agree that views like those of KS Rep. Alford have no place in our statehouse, in our state or in our country.”
State Rep. Valdenia Winn (D), who represents part of Kansas City, called Alford’s comments “bizarre.”
Medical-marijuana company Aphria Inc. posted a 39 percent jump in second-quarter revenue to C$8.5 million ($6.8 million), exceeding the most recently reported figures of larger peer Aurora Cannabis Inc. and giving it the second-highest quarterly revenue of pot-specialty companies globally. Aphria remains upbeat, even as the increased legalization of marijuana is called into question after a move by U.S. Attorney General Jeff Sessions to revoke policies that allowed its spread and warnings of a possible de-listing. At a conference in Toronto on Wednesday, Chief Executive Officer Vic Neufeld stated plans for several acquisitions that will target expansion in four more states.
Attorney general to end lenient enforcement of federal marijuana laws, days after new legalization measure took effect in California
The US attorney general, Jeff Sessions, is rescinding an Obama-era policy that paved the way for legalized marijuana to flourish in states across the country, creating new confusion about enforcement and use just three days after a new legalization law went into effect in California.
Instead of the previous policy of lenient federal enforcement begun under former attorney general Eric Holder in 2013, Sessions new stance will instead let federal prosecutors where marijuana is legal decide how aggressively to enforce longstanding federal law prohibiting it. Guidance issued on Thursday depicted the change as a return to the rule of law.
It is the mission of the Department of Justice to enforce the laws of the United States, and the previous issuance of guidance undermines the rule of law and the ability of our local, state, tribal, and federal law enforcement partners to carry out this mission, Sessions said in a statement.
Sessions plan drew immediate strong objection from the Republican senator Cory Gardner of Colorado, one of eight states that have legalized marijuana for recreational use.
Gardner said in a tweet that the justice department has trampled on the will of the voters in Colorado and other states. He said the action would contradict what Sessions had told him before the attorney general was confirmed and that he was prepared to take all steps necessary to fight the step including holding up the confirmation of justice department nominees.
The move by Trumps attorney general is sure to add to confusion about whether its OK to grow, buy or use marijuana in states where the drug is legal. It comes just after shops opened in California, launching what is expected to become the worlds largest market for legal recreational marijuana.
This instability will only push consumer dollars away from these state-sanctioned businesses and back into the hands of criminal elements. With nearly two-thirds of Americans, including an outright majority of Republicans, Democrats and Independents supporting marijuana legalization, this is not just bad policy, but awful politics and the Trump administration should brace itself for the public backlash it will no doubt generate, said Erik Altieri, executive director of the National Organization for the Reform of Marijuana Laws.
Altieri also noted that the announcement throws the jobs of more than 150,000 Americans employed in the budding legal marijuana industry into limbo.
For politicians who purport to believe in small government and states rights, this is a wildly incongruous move, said Jesselyn McCurdy, deputy director at the American Civil Liberties Union.
While Sessions has been mostly been carrying out a justice department agenda that follows Trumps top priorities on such issues as immigration and opioids, the changes to marijuana policy reflect his own long-held concerns. Trumps personal views on marijuana remain largely unknown.
Dont panic, legalization advocates say: Jeff Sessions anti-marijuana policy will have little practical impact and may even hasten the formal end of prohibition
Now that the dust has settled around attorney general Jeff Sessions promise of harsher federal marijuana enforcement, advocates of legalization have largely exchanged their initial disappointment over the move for one of long-term optimism.
I think there was a knee-jerk reaction of something approaching panic, but once everyone calmed down, theyve come to realize that practically this is going to have little impact, said Patrick Moen, a former Drug Enforcement Agency (DEA) agent who now works as council to an investment firm in the nascent legal marijuana industry.
Some, like Moen, even believe the decision could be the best thing for the growing marijuana movement, hastening the formal end of weed prohibition in the US.
There will probably a short term chilling effect, but this could ultimately be the best thing thats ever happened to accelerate the pace of change, Moen said.
The markets have reflected this somewhat counterintuitive sentiment. The United States Marijuana Index, which tracks 15 leading publicly traded legal marijuana-related companies, initially dropped 21% on the heels of the Department of Justice (DoJ) announcement, but it turned out to be a blip. By early this week the index had rebounded to within a few points of its one-year high.
Sessions announcement formally rescinded guidance, known as the Cole Memo, issued by the Obama-era DoJ that essentially told federal prosecutors to respect state laws with regards to marijuana. Importantly, though, Sessions decision did not direct or incentivize US attorneys to pursue marijuana cases, it just allowed them to if they so choose.
The Cole Memo guidance was eminently reasonable and was a common sense good policy, Moen said. I think that despite the fact that its been formally rescinded, federal prosecutors will effectively continue to abide by it.
Earlier today, real-life “Dukes of Hazzard” villain Jefferson Beauregard Sessions III announced plans to crack down on marijuana in states that have legalized it.
In a three-paragraph Justice Department memo, Sessions directed U.S. attorneys to disregard past policy about turning a somewhat blind eye to pot when it came to the more than two dozen states that have legalized it for medicinal or recreational use, saying, “Today’s memo on federal marijuana enforcement simply directs all U.S. attorneys to use previously established prosecutorial principles that provide them all the necessary tools to disrupt criminal organizations, tackle the growing drug crisis, and thwart violent crime across our country.”
Photo by Saul Loeb/AFP/Getty Images.
The official Twitter account for the Colorado state Senate Democrats took aim at Sessions’ push in a thread equal parts informative and amusing.
Legal weed has been around in Colorado for quite awhile, with voters approving a medical marijuana ballot measure way back in 2000, and giving the thumbs up to recreational use in 2012.
By most accounts, legal weed in Colorado has been a pretty big hit — which Colorado’s Senate Democrats laid out in excruciating detail.
Hearing news about Sessions’ plan to fight the states on this, they kicked off an epic Twitter thread with what’s just a clearly great joke: “We’ll give Jeff Sessions our legal pot when he pries it from our warm, extremely interesting to look at hands.”
We’ll give Jeff Sessions our legal pot when he pries it from our warm, extremely interesting to look at hands. https://t.co/LF0RpdCiHG
With that one-liner out of the way, they laid out a really strong case for letting states handle this. For one, it’s really, really been great for the economy. “Since legalization, marijuana has generated $617,767,334 in tax revenue,” read one of the tweets. “Instead of going to drug cartels, that money helps fund our schools and addiction treatment programs for more dangerous drugs.”
The marijuana industry supports hundreds of small businesses across our state.
Since legalization, marijuana has generated $617,767,334 in tax revenue. Instead of going to drug cartels, that money helps fund our schools and addiction treatment programs for more dangerous drugs.
They concluded as they started: with a joke. “If only there was some way we could mellow him out,” they pondered.
Instead of using taxpayer resources to go after a drug that’s safer than alcohol, Jeff Sessions should focus on political corruption and white collar crime. Seems like there’s plenty of that to go around in DC.
If only there was some way we could mellow him out 🤔
If there’s one thing we can all learn from this, it’s how hollow the convictions of those who champion “states’ rights” and “small government” can be.
Whether it’s in fighting states’ abilities to enact their own laws around pot, micromanaging what a woman can do with her uterus, demanding to know what a trans person’s genitals look like, or dictating who has the right to protest for racial justice and how they should do it, “small government” often means complete authoritarian control. Perhaps these politicians should heed a bit of their own rhetoric. “Don’t tread on me,” right?
(CNN)Jeff Sessions announced Thursday that he is rescinding the Cole memo, which reflected the Department of Justice’s relatively passive policy under the Obama administration since August 2013 on enforcement of federal cannabis laws.
Unlike announcements from the DOJ in past years threatening to ramp up federal enforcement of the cannabis laws, this announcement was met with little more than a yawn by cannabis businesses.
Now, unlike in prior years, government officials in California and elsewhere are totally aligned with cannabis businesses in resisting the federal government’s threats.
In fact, the landscape has shifted so dramatically in recent years that some of the harshest critics of Sessions were senators and representatives, many of them prominent Republicans, from states with cannabis programs that generate much-needed medicine and tax revenue. They expressed outrage over this action by Sessions, claiming it belies promises he made to them before being confirmed by the Senate.
As a result, Sessions has alienated many in Congress, where he can ill afford to lose any friends. Given his recusal — apparently against President Donald Trump’s wishes — from the Russia collusion investigation, he seems to be in a vulnerable spot with the President. Trump has said that he still stands with Sessions. But the attorney general still faces allegations from Democrats, who say that he perjured himself during last year’s confirmation hearings.
Without protection from Republican allies in the Senate, Sessions’ next appearance on Capitol Hill could be bloody. Cannabis might be the issue that undermines Sessions’ already shaky support.
Apart from Sessions’ announcement being unpopular, it really doesn’t have any teeth. The medical and legal cannabis industry has grown so big that it would be impossible to make a dent in it — let alone stamp it out through federal enforcement.
Moreover, Sessions did not actually announce that there would be a crackdown on cannabis businesses, but rather that it would be left to the discretion of the local US attorneys in the various districts to decide how and when to enforce the federal laws. This does not amount to much of a substantive change in policy, which begs the question of why Sessions bothered to make the announcement at all.
The Obama administration’s policy essentially left it to the individual states to regulate its respective cannabis industries provided those businesses did not engage in activities that threatened federal priorities, like serving as a cover for other illegal activity or violence.
GOP senator fumes over marijuana memo reversal
Under the Cole memo, in the past four-plus years, the already robust medical cannabis industry continued to evolve with more than half the states now allowing some form of medical cannabis use and commercial activity, and now eight states including California, Colorado, Washington and Nevada permitting recreational or adult use of recreational cannabis.
The Sessions’ announcement was likely timed to create anxiety in California, only days after it began issuing permits for both medical and recreational cannabis businesses. California and its attorney general have been somewhat of a thorn in the side of the Trump administration, filing a number of lawsuits challenging various policies, and perhaps most significantly, allowing so-called “sanctuary cities” for undocumented immigrants.
It would be wise for Sessions to remember that cannabis businesses exist in red and purple states, too. Its investors include prominent Trump supporters like Todd Mitchem. Any real enforcement efforts would alienate this administration’s base and be a political risk.
For all of these reasons, there isn’t much bark to Sessions’ bite. And in fact, it could precipitate a legal battle with California and other states — possibly overturning the authority of the federal government to even regulate legal cannabis businesses, an issue that has yet to be decided by the Supreme Court. That would be the ultimate irony to Sessions’ move and an appropriate epitaph on his fight against cannabis.
States around the country — 29 of them, plus Washington DC — have legalized medical marijuana.
The American public largely supports the legalization of medical marijuana. At least 84% of the public believes the drug should be legal for medical uses, and recreational pot usage is less controversial than ever, with at least 61% of Americans in support.
Even though some medical benefits of smoking pot may be overstated by advocates of marijuana legalization, recent research has demonstrated that there are legitimate medical uses for marijuana and strong reasons to continue studying the drug’s medicinal uses.
There are at least two active chemicals in marijuana that researchers think have medicinal applications. Those are cannabidiol (CBD) — which seems to impact the brain without a high— and tetrahydrocannabinol (THC) — which has pain relieving properties and is largely responsible for the high.
But scientists say that limitations on marijuana research mean we still have big questions about its medicinal properties. In addition to CBD and THC, there are another 400 or so chemical compounds, more than 60 of which are cannabinoids. Many of these could have medical uses. But without more research, we won’t know how to best make use of those compounds.
More research would also shed light on the risks of marijuana. Even if there are legitimate uses for medicinal marijuana, that doesn’t mean all use is harmless. Some research indicates that chronic, heavy users may have impaired memory, learning, and processing speed, especially if they started regularly using marijuana before age 16 or 17.
For some of the following medical benefits, there’s good evidence. For others, there’s reason to continue conducting research.
Jennifer Welsh contributed to an earlier version of this story.
The best-supported medicinal use of marijuana is as a treatment for chronic pain.
A recent report by the National Academies of Sciences, Engineering, and Medicine said there was definitive evidence that cannabis or cannabinoids (which are found in the marijuana plant) can be an effective treatment for chronic pain.
The report said that is “by far the most common” reason people request medical marijuana.
There’s also strong evidence medical cannabis can help with muscle spasms.
That same report said there’s equally strong evidence marijuana can help with muscle spasms related to multiple sclerosis.
Other types of muscle spasms respond to marijuana as well. People use medical marijuana to treat diaphragm spasms that are untreatable by other, prescribed medications.
It doesn’t seem to harm lung capacity, and may even improve it.
Researchers looking for risk factors of heart disease tested the lung function of 5,115 young adults over the course of 20 years. Tobacco smokers lost lung function over time, but pot users actually showed an increase in lung capacity.
It’s possible that the increased lung capacity may be due to taking a deep breaths while inhaling the drug and not from a therapeutic chemical in the drug.
The smokers in that study only toked up a few times a month, but a more recent survey of people who smoked pot daily for up to 20 years found no evidence that smoking pot harmed their lungs, either.
The National Academies report said there are good studies showing marijuana users are not more likely to have cancers associated with smoking.
It may be of some use in treating glaucoma, or it may be possible to derive a drug from marijuana for this use.
Marijuana decreases the pressure inside the eye, according to the National Eye Institute: “Studies in the early 1970s showed that marijuana, when smoked, lowered intraocular pressure (IOP) in people with normal pressure and those with glaucoma.”
For now, the medical consensus is that marijuana only lowers IOP for a few hours, meaning there’s not good evidence for it as a long term treatment right now. Researchers hope that perhaps a marijuana-based compound could be developed that lasts longer.
It may help control epileptic seizures.
Some studies have shown that cannabidiol (CBD), another major marijuana compound, seems to help people with treatment-resistant epilepsy.
A number of individuals have reported that marijuana is the only thing that helps control their or their children’s seizures.
However, there haven’t been many gold-standard, double-blind studies on the topic, so researchers say more data is needed before we know how effective marijuana is.
It also decreases the symptoms of a severe seizure disorder known as Dravet’s Syndrome.
During the research for his documentary “Weed,” Sanjay Gupta interviewed the Figi family, who treated their 5-year-old daughter using a medical marijuana strain high in cannabidiol and low in THC.
The Figi family’s daughter, Charlotte, has Dravet Syndrome, which causes seizures and severe developmental delays.
According to the film, the drug decreased her seizures from 300 a week to just one every seven days. Forty other children in the state were using the same strain of marijuana to treat their seizures when the film was made — and it seemed to be working.
The doctors who recommended this treatment said the cannabidiol in the plant interacts with brain cells to quiet the excessive activity in the brain that causes these seizures.
Gupta notes, however, that a Florida hospital that specializes in the disorder, the American Academy of Pediatrics, and the Drug Enforcement agency don’t endorse marijuana as a treatment for Dravet or other seizure disorders.
A chemical found in marijuana stops cancer from spreading, at least in cell cultures.
One 2014 study found that marijuana can significantly slow the growth of the type of brain tumor associated with 80% of malignant brain cancer in people.
Still, these findings in cell cultures and animals don’t necessarily mean the effect will translate to people — far more investigation is needed.
It may decrease anxiety in low doses.
Researchers know that many cannabis users consume marijuana to relax, but also that many people say smoking too much can cause anxiety. So scientists conducted a study to find the “Goldilocks” zone: the right amount of marijuana to calm people.
According to Emma Childs, an associate professor of psychiatry at the University of Illinois at Chicago and an author of the study, “we found that THC at low doses reduced stress, while higher doses had the opposite effect.”
A few puffs was enough to help study participants relax, but a few puffs more started to amp up anxiety. However, people may react differently in different situations.
THC may slow the progression of Alzheimer’s disease
The 2006 study, published in the journal Molecular Pharmaceutics, found that THC (the active chemical in marijuana) slows the formation of amyloid plaques by blocking the enzyme in the brain that makes them. These plaques kill brain cells and are associated with Alzheimer’s.
Jody Corey-Bloom studied 30 multiple sclerosis patients with painful contractions in their muscles. These patients didn’t respond to other treatments, but after smoking marijuana for a few days, they reported that they were in less pain.
The THC in marijuana seems to bind to receptors in the nerves and muscles to relieve pain.
It seems to lessen side effects from treating hepatitis C and increase treatment effectiveness.
Treatment for hepatitis C infection is harsh: negative side effects include fatigue, nausea, muscle aches, loss of appetite, and depression. Those side effects can last for months, and lead many people to stop their treatment course early.
But a 2006 study in the European Journal of Gastroenterology and Hepatology found that 86% of patients using marijuana successfully completed their Hep C therapy. Only 29% of non-smokers completed their treatment, possibly because the marijuana helps lessen the treatment’s side effects.
Marijuana also seems to improve the treatment’s effectiveness: 54% of hep C patients smoking marijuana got their viral levels low and kept them low, in comparison to only 8% of nonsmokers.
Marijuana may help with inflammatory bowel diseases.
University of Nottingham researchers found in 2010 that chemicals in marijuana, including THC and cannabidiol, interact with cells in the body that play an important role in gut function and immune responses. The study was published in the Journal of Pharmacology and Experimental Therapeutics.
The body makes THC-like compounds that increase the permeability of the intestines, allowing bacteria in. But the cannabinoids in marijuana block these compounds, making the intestinal cells bond together tighter and become less permeable.
But the National Academies report said there isn’t enough evidence to be sure whether marijuana really helps with these conditions, so more research is needed.
Researchers from rheumatology units at several hospitals gave their patients Sativex, a cannabinoid-based pain-relieving medicine. After a two-week period, people on Sativex had a significant reduction in pain and improved sleep quality compared to placebo users.
Other studies have found that plant-derived cannabinoids and inhaled marijuana can decrease arthritis pain, according to the National Academies report.
Marijuana users tend to be less obese and have a better response to eating sugar.
A study published in the American Journal Of Medicine suggested that pot smokers are skinnier than the average person and have healthier metabolism and reaction to sugars, even though they do end up eating more calories.
The study analyzed data from more than 4,500 adult Americans — 579 of whom were current marijuana smokers, meaning they had smoked in the last month. About 2,000 people had used marijuana in the past, while another 2,000 had never used the drug.
The researchers studied how the participants’ bodies responded to eating sugars. They measured blood-sugar levels and the hormone insulin after participants hadn’t eaten in nine hours, and after they’d eaten sugar.
Not only were pot users thinner, their bodies also had a healthier response to sugar. Of course, the study couldn’t determine whether the marijuana users were like this to begin with or if these characteristics were somehow related to their smoking.
While not really a health or medical benefit, marijuana could spur creativity.
Contrary to stoner stereotypes, marijuana usage has actually been shown to have some positive mental effects, particularly in terms of increasing creativity, at least in some contexts. Even though people’s short-term memories tend to function worse when they’re high, they actually get better at tests requiring them to come up with new ideas.
Researchers have also found that some study participants improve their “verbal fluency,” their ability to come up with different words, while using marijuana.
Part of this increased creative ability may come from the release of dopamine in the brain, which lowers inhibitions and allows people to feel more relaxed, giving the brain the ability to perceive things differently.
Cannabis soothes tremors for people with Parkinson’s disease.
Medical marijuana is legal in Israel for multiple conditions, and a lot of research into the medical uses of cannabis is done there, supported by the Israeli government.
Marijuana may help veterans suffering from PTSD.
In 2014, the Colorado Department of Public Health awarded $2 million to the Multidisciplinary Association for Psychedelic Studies (one of the biggest proponents of marijuana research) to study marijuana’s potential for people with post-traumatic stress disorder.
Naturally occurring cannabinoids, similar to THC, help regulate the system that causes fear and anxiety in the body and brain.
Marijuana is approved to treat PTSD in some states already — in New Mexico, PTSD is the number one reason for people to get a license for medical marijuana.
But there are still questions about the safety of using marijuana while suffering from PTSD, which this study — which has taken a while to get off the ground — will hopefully help answer.
Animal studies suggest that marijuana may protect the brain after a stroke.
Research from the University of Nottingham shows that marijuana may help protect the brain from damage from a stroke by reducing the size of the area affected by the stroke — at least in rats, mice, and monkeys.
This isn’t the only research that has shown neuroprotective effects of cannabis. Some research shows that the plant may help protect the brain after other types of brain trauma.
Marijuana might even protect the brain from concussions and trauma.
Lester Grinspoon , a professor of psychiatry at Harvard and marijuana advocate, recently wrote an open letter to NFL Commissioner Roger Goodell. In it, he said the NFL should stop testing players for marijuana, and that the league should start funding research into the plant’s ability to protect the brain instead.
This is a complicated one, because it involves effects that can be both positive and negative. Marijuana disturbs sleep cycles by interrupting the later stages of REM sleep. In the long run, this could be a problem for frequent users.
However, for people suffering from serious nightmares, especially those associated with PTSD, this can be helpful, perhaps in the short term. Nightmares and other dreams occur during those same stages of sleep. By interrupting REM sleep, many of those dreams may not occur. Research into using a synthetic cannabinoid — similar to THC but not the same — showed a significant decrease in the number of nightmares in patients with PTSD.
Additionally, even if frequent use can be bad for sleep, marijuana may be a better sleep aid than some other substances that people use. Some of those, including medication and alcohol, may potentially have worse effects on sleep, though more research is needed on the topic.
Cannabis reduces some of the pain and nausea from chemotherapy and stimulates appetite.
One of the most well-known medical uses of marijuana is for people going through chemotherapy. There’s good evidence that it’s effective for this, according to the National Academies report.
Cancer patients being treated with chemo suffer from painful nausea, vomiting, and loss of appetite. This can cause additional health complications.
Marijuana can help reduce these side effects, alleviating pain, decreasing nausea, and stimulating the appetite. There are also multiple FDA-approved cannabinoid drugs that use THC, the main active chemical in marijuana, for the same purpose.
Marijuana can help people who are trying to cut back on drinking.
Marijuana is safer than alcohol. That’s not to say it’s risk-free, but cannabis is much less addictive than alcohol and doesn’t cause nearly as much physical damage.
Research published in the Harm Reduction Journal found that some people use marijuana as a less harmful substitute for alcohol, prescription drugs, and other illegal drugs. Some of the most common reasons patients make that substitution are that marijuana has less negative side effects and is less likely to cause withdrawal problems.
Some people do become psychologically dependent on marijuana, and it is not a cure for substance abuse problems. But from a harm-reduction standpoint, it can help.
Still, it’s worth noting that combining marijuana and alcohol can be dangerous, and some researchers are concerned that this scenario is more likely than one in which users substitute a toke for a drink.
Medical marijuana legalization seems to reduce opioid overdose deaths.
While there are a number of factors behind the current opioid epidemic, many experts agree that the use of opioid painkillers to treat chronic pain has played a major role. It’s very risky to take powerful drugs that have a high risk of causing overdose and high addiction rates. Marijuana, which can also treat chronic pain, is far less risky.
Several studies have shown that states that allow medical marijuana have fewer opioid deaths. This effect seems to grow over time, with states who pass these laws seeing a “20% lower rate of opioid deaths in the laws’ first year, 24% in the third, and 33% in the sixth,” according to Stat News.
It’s hard to say that deaths went down because of medical marijuana legalization and not other reasons. But because the effect seems to get stronger the longer marijuana remains legal, researchers think marijuana is a likely cause of the decline in opioid deaths.
Read the original article on Business Insider. Follow us on Facebook and Twitter. Copyright 2017.
Attorney General Jeff Sessions is expected to announce today that President Donald Trump‘s administration will reverse an Obama-era policy that instructed the federal government to take a hands-off approach with states that decide to legalize marijuana.
Instead, Sessions is expected to say federal prosecutors will have the ability to decide how to enforce pot laws.
The decision to flip to a harsher stance on marijuana comes amid a majority of Americans believing cannabis should be legal for recreational use and just days after California allowed shops to sell legal, recreational pot.
The Associated Press first reported on the administration’s expected decision.
Several states and the District of Columbia have legalized marijuana, with some states—such as New Jersey—expected to follow suit. Despite growing momentum from states, pot is still illegal under federal law.
Recent polls found 94 percent of voters support adults using marijuana legally for medicinal purposes and 64 percent of Americans think pot should be made legal.
Under the new rules, Sessions is expected to say U.S. attorneys will now have the ability to decide how to enforce marijuana laws and direct said enforcement. The 2013 guidance from the Obama administration protected legalized cannabis from federal intervention as long as it did not interfere with other priorities.
Sessions has long had an adversarial view on pot. Last summer he asked Congress to give him authority to go after medical marijuana patients and distributors, which was rebuffed by the Senate Appropriations Committee.
Sen. Cory Gardner (D-Colo.) said today that this move by Sessions broke a personal promise to him.
Dave Rubin is defending free speech from progressives
This reported action directly contradicts what Attorney General Sessions told me prior to his confirmation. With no prior notice to Congress, the Justice Department has trampled on the will of the voters in CO and other states.